Financial Performance - The company's revenue for Q1 2023 was ¥2,233,266,009.68, a decrease of 28.40% compared to ¥3,119,046,203.43 in the same period last year[3] - Net profit attributable to shareholders was ¥182,814,094.72, down 52.83% from ¥387,571,013.34 year-on-year[3] - Basic earnings per share decreased to ¥0.66, a decline of 52.86% from ¥1.40 in the previous year[3] - The net profit for the current period is approximately ¥193.45 million, a decrease of 50.8% compared to ¥392.63 million in the previous period[18] - The total comprehensive income for the current period is approximately ¥162.72 million, down from ¥361.76 million in the previous period, reflecting a decline of 55.0%[18] Cash Flow and Liquidity - The net cash flow from operating activities was -¥438,843,869.41, representing a 95.72% decrease compared to -¥224,220,205.58 in the same period last year[3] - Cash flow from operating activities shows a net outflow of approximately ¥438.84 million, worsening from a net outflow of ¥224.22 million in the previous period[19] - Cash inflow from operating activities totaled approximately ¥3.07 billion, an increase from ¥2.90 billion in the previous period[19] - Cash outflow from operating activities increased to approximately ¥3.51 billion, compared to ¥3.12 billion in the previous period[19] - The ending cash and cash equivalents balance is approximately ¥2.05 billion, compared to ¥1.89 billion in the previous period, indicating an increase[20] - The company reported a foreign exchange loss impacting cash and cash equivalents of approximately ¥11.56 million, compared to a loss of ¥3.15 million in the previous period[20] Assets and Liabilities - Total assets at the end of Q1 2023 were ¥10,819,638,626.46, down 6.72% from ¥11,598,874,181.42 at the end of the previous year[3] - Total liabilities decreased to CNY 4,250,997,347.78 from CNY 5,211,651,173.61, indicating improved debt management[15] - The equity attributable to shareholders increased to CNY 6,362,719,929.70 from CNY 6,184,265,166.56, showing a positive trend in retained earnings[15] Expenses - Sales expenses increased by 61.62% to ¥75,879,447.34, primarily due to higher employee compensation and registration costs[7] - Financial expenses rose by 50.84% to ¥60,017,682.80, mainly due to increased exchange losses from currency fluctuations[7] - The company's net profit margin has been impacted, with a significant increase in sales expenses to CNY 75,879,447.34, up from CNY 46,948,661.90[16] - Research and development expenses decreased to CNY 56,162,380.67 from CNY 89,023,043.97, indicating a strategic shift in R&D focus[16] Investment and Shareholding - The company reported an investment loss of CNY 35,302,194.73, contrasting with a gain of CNY 28,854,869.96 in the previous period[16] - 山东润源投资有限公司持股比例为41.47%，持有股份数量为114,911,237股[9] - KONKIA INC持股比例为22.08%，持有股份数量为61,191,800股[9] - 山东润农投资有限公司持股比例为4.73%，持有股份数量为13,105,690股[9] - 济南信博投资持股比例为2.83%，持有股份数量为7,840,686股[9] - 裴旭波持股比例为2.81%，持有股份数量为7,800,011股[9] - 中国工商银行股份有限公司－交银施罗德趋势优先混合型证券投资基金持股比例为2.74%，持有股份数量为7,587,490股[9] - 香港中央结算有限公司持股比例为2.12%，持有股份数量为5,863,976股[9] - 东方证券股份有限公司－中庚价值先锋股票型证券投资基金持股比例为1.75%，持有股份数量为4,843,468股[9] - 招商银行股份有限公司－交银施罗德启诚混合型证券投资基金持股比例为0.73%，持有股份数量为2,009,964股[9] - 中国建设银行股份有限公司－国泰大健康股票型证券投资基金持股比例为0.57%，持有股份数量为1,577,667股[9] Future Strategy - The company plans to focus on market expansion and new product development as part of its future strategy[16]
润丰股份(301035) - 2023 Q1 - 季度财报